miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α

References

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Segura MF, Greenwald HS, Hanniford D, Osman I, Hernando E. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis 2012; 33:1823-32; PMID:22693259; http://dx.doi.org/10.1093/carcin/bgs205
   PubMed Web of Science ®Google Scholar
• Dong F, Lou D. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. Mol Vis 2012; 18:537-46; PMID:22419847
   PubMed Web of Science ®Google Scholar
• Luo C, Tetteh PW, Merz PR, Dickes E, Abukiwan A, Hotz-Wagenblatt A, Holland-Cunz S, Sinnberg T, Schittek B, Schadendorf D, et al. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes. J Invest Dermatol 2013; 133:768-75; PMID:23151846; http://dx.doi.org/10.1038/jid.2012.357
   PubMed Web of Science ®Google Scholar
• Dar AA, Majid S, Rittsteuer C, de Semir D, Bezrookove V, Tong S, Nosrati M, Sagebiel R, Miller JR 3rd, Kashani-Sabet M. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst 2013; 105:433-42; PMID:23365201; http://dx.doi.org/10.1093/jnci/djt003
   PubMed Web of Science ®Google Scholar
• Giles KM, Brown RA, Epis MR, Kalinowski FC, Leedman PJ. miRNA-7-5p inhibits melanoma cell migration and invasion. Biochem Biophys Res Commun 2013; 430:706-10; PMID:23206698; http://dx.doi.org/10.1016/j.bbrc.2012.11.086
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Schmitz U, Wolkenhauer O, Schonherr M, Raatz Y, Kunz M. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma. Oncogene 2013; 32:3175-83; PMID:22847610; http://dx.doi.org/10.1038/onc.2012.324
   PubMed Web of Science ®Google Scholar
• Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A 2009; 106:1814-9; PMID:19188590; http://dx.doi.org/10.1073/pnas.0808263106
   PubMed Web of Science ®Google Scholar
• Zehavi L, Avraham R, Barzilai A, Bar-Ilan D, Navon R, Sidi Y, Avni D, Leibowitz-Amit R. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol cancer 2012; 11:44; PMID:22747855; http://dx.doi.org/10.1186/1476-4598-11-44
   PubMed Web of Science ®Google Scholar
• Chen J, Abi-Daoud M, Wang A, Yang X, Zhang X, Feilotter HE, Tron VA. Stathmin 1 is a potential novel oncogene in melanoma. Oncogene 2013; 32:1330-7; PMID:22665054; http://dx.doi.org/10.1038/onc.2012.141
   PubMed Web of Science ®Google Scholar
• Xu D, Tan J, Zhou M, Jiang B, Xie H, Nie X, Xia K, Zhou J. Let-7b and microRNA-199a inhibit the proliferation of B16F10 melanoma cells. Oncol Lett 2012; 4:941-6; PMID:23162627
   PubMed Web of Science ®Google Scholar
• Hanna SC, Krishnan B, Bailey ST, Moschos SJ, Kuan PF, Shimamura T, Osborne LD, Siegel MB, Duncan LM, O'Brien ET 3rd, et al. HIF1alpha and HIF2alpha independently activate SRC to promote melanoma metastases. J Clin Invest 2013; 123:2078-93; PMID:23563312; http://dx.doi.org/10.1172/JCI66715
   PubMed Web of Science ®Google Scholar
• Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Näär AM. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010; 328:1566-9; PMID:20466882; http://dx.doi.org/10.1126/science.1189123
   PubMed Web of Science ®Google Scholar
• Davalos A, Goedeke L, Smibert P, Ramirez CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U, Pastor-Pareja JC, et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A 2011; 108:9232-7; PMID:21576456; http://dx.doi.org/10.1073/pnas.1102281108
   PubMed Web of Science ®Google Scholar
• Ramirez CM, Goedeke L, Rotllan N, Yoon JH, Cirera-Salinas D, Mattison JA, Suárez Y, de Cabo R, Gorospe M, Fernández-Hernando C, et al. MicroRNA 33 regulates glucose metabolism. Mol Cell Biol 2013; 33:2891-902; PMID:23716591; http://dx.doi.org/10.1128/MCB.00016-13
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X, et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011; 478:404-7; PMID:22012398; http://dx.doi.org/10.1038/nature10486
   PubMed Web of Science ®Google Scholar
• Cirera-Salinas D, Pauta M, Allen RM, Salerno AG, Ramirez CM, Chamorro-Jorganes A, Wanschel AC, Lasuncion MA, Morales-Ruiz M, Suarez Y, et al. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 2012; 11:922-33; PMID:22333591; http://dx.doi.org/10.4161/cc.11.5.19421
   PubMed Web of Science ®Google Scholar
• Thomas M, Lange-Grunweller K, Weirauch U, Gutsch D, Aigner A, Grunweller A, Hartmann RK. The proto-oncogene Pim-1 is a target of miR-33a. Oncogene 2012; 31:918-28; PMID:21743487; http://dx.doi.org/10.1038/onc.2011.278
   PubMed Web of Science ®Google Scholar
• Rice SJ, Lai SC, Wood LW, Helsley KR, Runkle EA, Winslow MM, Mu D. MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1). J Biol Chem 2013; 288:16348-60; PMID:23625920; http://dx.doi.org/10.1074/jbc.M113.474643
   PubMed Web of Science ®Google Scholar
• Kuo PL, Liao SH, Hung JY, Huang MS, Hsu YL. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochimica et biophysica acta 2013; 1830:3756-66; PMID:23458685; http://dx.doi.org/10.1016/j.bbagen.2013.02.022
   PubMed Web of Science ®Google Scholar
• Friedman EB, Shang S, de Miera EV, Fog JU, Teilum MW, Ma MW, Berman RS, Shapiro RL, Pavlick AC, Hernando E, et al. Serum microRNAs as biomarkers for recurrence in melanoma. J Transl Med 2012; 10:155; PMID:22857597; http://dx.doi.org/10.1186/1479-5876-10-155
   PubMed Web of Science ®Google Scholar
• Liu S, Tetzlaff MT, Liu A, Liegl-Atzwanger B, Guo J, Xu X. Loss of microRNA-205 expression is associated with melanoma progression. Lab Invest 2012; 92:1084-96; PMID:22525428; http://dx.doi.org/10.1038/labinvest.2012.62
   PubMed Web of Science ®Google Scholar
• Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, Guo W, Xu X. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-kappaB1-Snail1 pathway in melanoma. J Pathol 2012; 226:61-72; PMID:22131135; http://dx.doi.org/10.1002/path.2964
   PubMed Web of Science ®Google Scholar
• Kappelmann M, Kuphal S, Meister G, Vardimon L, Bosserhoff AK. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene 2013; 32:2984-91; PMID:22797068; http://dx.doi.org/10.1038/onc.2012.307
   PubMed Web of Science ®Google Scholar
• Nys K, Maes H, Dudek AM, Agostinis P. Uncovering the role of hypoxia inducible factor-1alpha in skin carcinogenesis. Biochimica et biophysica acta 2011; 1816:1-12; PMID:21338656
   PubMed Web of Science ®Google Scholar
• Bedogni B, Welford SM, Cassarino DS, Nickoloff BJ, Giaccia AJ, Powell MB. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell 2005; 8:443-54; PMID:16338658; http://dx.doi.org/10.1016/j.ccr.2005.11.005
   PubMed Web of Science ®Google Scholar
• Kuphal S, Winklmeier A, Warnecke C, Bosserhoff AK. Constitutive HIF-1 activity in malignant melanoma. Eur J Cancer 2010; 46:1159-69; PMID:20185296; http://dx.doi.org/10.1016/j.ejca.2010.01.031
   PubMed Web of Science ®Google Scholar
• Sun B, Zhang D, Zhang S, Zhang W, Guo H, Zhao X. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett 2007; 249:188-97; PMID:16997457; http://dx.doi.org/10.1016/j.canlet.2006.08.016
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Sivridis E, Kouskoukis C, Gatter KC, Harris AL, Koukourakis MI. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res 2003; 13:493-501; PMID:14512791; http://dx.doi.org/10.1097/00008390-200310000-00008
   PubMed Web of Science ®Google Scholar
• Victor N, Ivy A, Jiang BH, Agani FH. Involvement of HIF-1 in invasion of Mum2B uveal melanoma cells. Clin Exp Metastasis 2006; 23:87-96; PMID:16826425; http://dx.doi.org/10.1007/s10585-006-9024-z
   PubMed Web of Science ®Google Scholar
• Cheli Y, Giuliano S, Fenouille N, Allegra M, Hofman V, Hofman P, Bahadoran P, Lacour JP, Tartare-Deckert S, Bertolotto C, et al. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 2012; 31:2461-70; PMID:21996743; http://dx.doi.org/10.1038/onc.2011.425
   PubMed Web of Science ®Google Scholar
• Iervolino A, Trisciuoglio D, Ribatti D, Candiloro A, Biroccio A, Zupi G, Del Bufalo D. Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. FASEB J 2002; 16:1453-5; PMID:12205045
   PubMed Web of Science ®Google Scholar
• Kluza J, Corazao-Rozas P, Touil Y, Jendoubi M, Maire C, Guerreschi P, Jonneaux A, Ballot C, Balayssac S, Valable S, et al. Inactivation of the HIF-1alpha/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Cancer Res 2012; 72:5035-47; PMID:22865452; http://dx.doi.org/10.1158/0008-5472.CAN-12-0979
   PubMed Web of Science ®Google Scholar
• Paradziej-Lukowicz J, Skwarska A, Peszynska-Sularz G, Brillowska-Dabrowska A, Konopa J. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1alpha (HIF-1alpha), vascular endothelial growth factor (VEGF) and angiogenesis. Cancer Biol Ther 2011; 12:586-97; PMID:21775820; http://dx.doi.org/10.4161/cbt.12.7.15980
   PubMed Web of Science ®Google Scholar
• Huynh C, Segura MF, Gaziel-Sovran A, Menendez S, Darvishian F, Chiriboga L, Levin B, Meruelo D, Osman I, Zavadil J, et al. Efficient in vivo microRNA targeting of liver metastasis. Oncogene 2011; 30:1481-8; PMID:21102518; http://dx.doi.org/10.1038/onc.2010.523
   PubMed Web of Science ®Google Scholar
• Chen X, Lin J, Kanekura T, Su J, Lin W, Xie H, Wu Y, Li J, Chen M, Chang J. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. Cancer Res 2006; 66:11323-30; PMID:17145878; http://dx.doi.org/10.1158/0008-5472.CAN-06-1536
   PubMed Web of Science ®Google Scholar